Folgen
Francisco J Cueto
Francisco J Cueto
Sara Borrell fellow at IdiPAZ
Bestätigte E-Mail-Adresse bei correo.ugr.es
Titel
Zitiert von
Zitiert von
Jahr
Dendritic cells in cancer immunology and immunotherapy
SK Wculek, FJ Cueto, AM Mujal, I Melero, MF Krummel, D Sancho
Nature Reviews Immunology 20 (1), 7-24, 2020
16542020
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
KC Barry, J Hsu, ML Broz, FJ Cueto, M Binnewies, AJ Combes, ...
Nature medicine 24 (8), 1178-1191, 2018
7822018
Cancer immunotherapy with immunomodulatory anti-CD137 and anti–PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells
AR Sánchez-Paulete, FJ Cueto, M Martínez-López, S Labiano, ...
Cancer discovery 6 (1), 71-79, 2016
4372016
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells
M Enamorado, S Iborra, E Priego, FJ Cueto, JA Quintana, ...
Nature communications 8 (1), 16073, 2017
2572017
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
AR Sánchez-Paulete, A Teijeira, FJ Cueto, S Garasa, JL Pérez-Gracia, ...
Annals of Oncology 28, xii44-xii55, 2017
2562017
Optimal generation of tissue-resident but not circulating memory T cells during viral infection requires crosspriming by DNGR-1+ dendritic cells
S Iborra, M Martínez-López, SC Khouili, M Enamorado, FJ Cueto, ...
Immunity 45 (4), 847-860, 2016
2022016
Rational design of adjuvants targeting the C-type lectin Mincle
A Decout, S Silva-Gomes, D Drocourt, S Barbe, I André, FJ Cueto, T Lioux, ...
Proceedings of the National Academy of Sciences 114 (10), 2675-2680, 2017
1092017
Leishmania uses mincle to target an inhibitory ITAM signaling pathway in dendritic cells that dampens adaptive immunity to infection
S Iborra, M Martínez-López, FJ Cueto, R Conde-Garrosa, C Del Fresno, ...
Immunity 45 (4), 788-801, 2016
962016
The Flt3L/Flt3 axis in dendritic cell biology and cancer immunotherapy
FJ Cueto, D Sancho
Cancers 13 (7), 1525, 2021
762021
Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections
P Brandi, L Conejero, FJ Cueto, S Martínez-Cano, G Dunphy, MJ Gomez, ...
Cell Reports 38 (1), 2022
422022
DNGR-1, a dendritic cell-specific sensor of tissue damage that dually modulates immunity and inflammation
FJ Cueto, C Del Fresno, D Sancho
Frontiers in immunology 10, 501026, 2020
352020
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
FJ Cueto, C Del Fresno, P Brandi, AJ Combes, E Hernández-García, ...
Journal for immunotherapy of cancer 9 (5), 2021
292021
Conventional type 1 dendritic cells protect against age-related adipose tissue dysfunction and obesity
E Hernández-García, FJ Cueto, ECL Cook, A Redondo-Urzainqui, ...
Cellular & molecular immunology 19 (2), 260-275, 2022
172022
Pleiotropic effects of antitumour alkylphospholipids on cholesterol transport and metabolism
P Ríos-Marco, C Marco, FJ Cueto, MP Carrasco, JM Jiménez-López
Experimental cell research 340 (1), 81-90, 2016
162016
Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element
S Marton, B Berzal-Herranz, E Garmendia, FJ Cueto, A Berzal-Herranz
Pharmaceuticals 5 (1), 49-60, 2011
132011
Toward tumor fight and tumor microenvironment remodeling: PBA induces cell cycle arrest and reduces tumor hybrid cells’ pluripotency in bladder cancer
C Rubio, J Avendaño-Ortiz, R Ruiz-Palomares, V Karaivanova, ...
Cancers 14 (2), 287, 2022
102022
Bacterial immunotherapy in children with wheezing attacks: clinical impact and mechanism of action
LC Hall, AN García, P Brandi, MN Cid, Á Mazón, FJ Cueto, ...
European Respiratory Journal 54 (suppl 63), 2019
82019
Sensing tissue damage by myeloid C-type lectin receptors
C Del Fresno, FJ Cueto, D Sancho
C-Type Lectins in Immune Homeostasis, 117-145, 2020
52020
A proposal for nomenclature in myeloid C-type lectin receptors
C Del Fresno, FJ Cueto, D Sancho
Frontiers in Immunology 10, 480011, 2019
32019
The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis
R Lozano-Rodríguez, J Avendaño-Ortíz, K Montalbán-Hernández, ...
EBioMedicine 97, 2023
12023
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20